Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation Research
Search: search_blue_button Advanced Search
Circulation Research. 2003;93:1127-1133
Published online before print October 30, 2003, doi: 10.1161/01.RES.0000103633.57225.BC
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
93/11/1127    most recent
01.RES.0000103633.57225.BCv1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lew, R.
Right arrow Articles by Sudhir, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lew, R.
Right arrow Articles by Sudhir, K.
Related Collections
Right arrow Pathophysiology
Right arrow Endothelium/vascular type/nitric oxide
Right arrow Mechanism of atherosclerosis/growth factors
(Circulation Research. 2003;93:1127.)
© 2003 American Heart Association, Inc.


Clinical Research

Endogenous Estrogens Influence Endothelial Function in Young Men

Robert Lew, Paul Komesaroff, Maro Williams, Tye Dawood, Krishnankutty Sudhir

From the Baker Medical Research Institute and Alfred Hospital, Prahran, Victoria, Australia, and Department of Medicine (K.S.), Stanford University, Stanford, Calif.

Correspondence to Krishnankutty Sudhir, MD, PhD, Stanford University, H3554, 300 Pasteur Dr, Stanford, CA 94305. E-mail ksudhir{at}cvmed.stanford.edu

Males produce endogenous estrogen from testosterone via the enzyme aromatase. Previous studies have suggested a role for endogenous estrogens in cardiovascular function in men. We examined the effects of endogenous estrogen suppression via aromatase inhibition on endothelial function, systemic arterial compliance, and lipoprotein levels in healthy young men. Using a placebo-controlled double-blind randomized design, 20 healthy men, aged 18 to 32 years, were randomized to receive either the aromatase inhibitor anastrozole (1 mg) or matching placebo. Hormone, lipid levels, C-reactive protein (CRP), and homocysteine were measured. Endothelial function, determined by flow-mediated dilation of the brachial artery, and systemic arterial compliance were assessed at baseline and after 6 weeks of treatment. There was a significant decrease in 17ß-estradiol concentrations with aromatase inhibition, from 85.4±4.2 to 64.3±8.1 pmol/L (mean±SD, P=0.042). Compared with baseline, a significant decrease in flow-mediated dilation was observed in subjects taking anastrozole [median, 6.1% (range, 5.2 to 13.4) to 3.5% (2.0 to 5.7), P=0.034] but not in the placebo group. No changes were observed in nitroglycerin-induced endothelium-independent dilation in either group. There was no change in systemic arterial compliance with either aromatase therapy or placebo. There were no significant changes in lipoproteins, testosterone, DHEA, CRP, or homocysteine levels in either the anastrozole or placebo group. We conclude that suppression of endogenous estrogens with an aromatase inhibitor resulted in impairment of flow-mediated dilation without significant changes in lipoproteins, homocysteine, or CRP. Our results suggest that endogenous estrogens play a direct regulatory role in endothelial function in young healthy men.


Key Words: estrogens • males • aromatase • endothelium • arterial compliance




This article has been cited by other articles:


Home page
Cardiovasc ResHome page
M. R. Meyer and M. Barton
ER{alpha}, ER{beta}, and gpER: novel aspects of oestrogen receptor signalling in atherosclerosis
Cardiovasc Res, September 1, 2009; 83(4): 605 - 610.
[Full Text] [PDF]


Home page
Eur J EndocrinolHome page
B Lapauw, G T'Sjoen, A Mahmoud, J M Kaufman, and J B Ruige
Short-term aromatase inhibition: effects on glucose metabolism and serum leptin levels in young and elderly men
Eur. J. Endocrinol., March 1, 2009; 160(3): 397 - 402.
[Abstract] [Full Text] [PDF]


Home page
Pharmacol. Rev.Home page
V. M. Miller and S. P. Duckles
Vascular Actions of Estrogens: Functional Implications
Pharmacol. Rev., June 1, 2008; 60(2): 210 - 241.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
G. Douglas, M. Natalia Cruz, L. Poston, J.-A. Gustafsson, and K. Kublickiene
Functional characterization and sex differences in small mesenteric arteries of the estrogen receptor- knockout mouse
Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2008; 294(1): R112 - R120.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
D. Sun, C. Yan, A. Jacobson, H. Jiang, M. A. Carroll, and A. Huang
Contribution of epoxyeicosatrienoic acids to flow-induced dilation in arteries of male ER{alpha} knockout mice: role of aromatase
Am J Physiol Regulatory Integrative Comp Physiol, September 1, 2007; 293(3): R1239 - R1246.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
T. Traupe, C. D. Stettler, H. Li, E. Haas, I. Bhattacharya, R. Minotti, and M. Barton
Distinct Roles of Estrogen Receptors {alpha} and {beta} Mediating Acute Vasodilation of Epicardial Coronary Arteries
Hypertension, June 1, 2007; 49(6): 1364 - 1370.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
H. R. N. Pour, D. E Grobbee, M. Muller, M. Emmelot-Vonk, and Y. T van der Schouw
Serum sex hormone and plasma homocysteine levels in middle-aged and elderly men
Eur. J. Endocrinol., December 1, 2006; 155(6): 887 - 893.
[Abstract] [Full Text] [PDF]


Home page
Endocr. Rev.Home page
J. L. Turgeon, M. C. Carr, P. M. Maki, M. E. Mendelsohn, and P. M. Wise
Complex Actions of Sex Steroids in Adipose Tissue, the Cardiovascular System, and Brain: Insights from Basic Science and Clinical Studies
Endocr. Rev., October 1, 2006; 27(6): 575 - 605.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. R. Meyer, E. Haas, and M. Barton
Gender Differences of Cardiovascular Disease: New Perspectives for Estrogen Receptor Signaling
Hypertension, June 1, 2006; 47(6): 1019 - 1026.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
M. N. Cruz, L. Luksha, H. Logman, L. Poston, S. Agewall, and K. Kublickiene
Acute responses to phytoestrogens in small arteries from men with coronary heart disease
Am J Physiol Heart Circ Physiol, May 1, 2006; 290(5): H1969 - H1975.
[Abstract] [Full Text] [PDF]


Home page
Eur J EndocrinolHome page
M. C M Bunck, A. W F T Toorians, P. Lips, and L. J G Gooren
The effects of the aromatase inhibitor anastrozole on bone metabolism and cardiovascular risk indices in ovariectomized, androgen-treated female-to-male transsexuals.
Eur. J. Endocrinol., April 1, 2006; 154(4): 569 - 575.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
V. M. Miller, D. J. Tindall, and P. Y. Liu
Of Mice, Men, and Hormones
Arterioscler Thromb Vasc Biol, June 1, 2004; 24(6): 995 - 997.
[Full Text] [PDF]


Home page
Circ. Res.Home page
K. Tsuda and I. Nishio
Role of Estrogens in the Regulation of Membrane Microviscosity
Circ. Res., February 6, 2004; 94 (2): e17 - e17.
[Full Text] [PDF]


Home page
CirculationHome page
S. Ling, A. Dai, R. J. Dilley, M. Jones, E. Simpson, P. A. Komesaroff, and K. Sudhir
Endogenous Estrogen Deficiency Reduces Proliferation and Enhances Apoptosis-Related Death in Vascular Smooth Muscle Cells: Insights From the Aromatase-Knockout Mouse
Circulation, February 3, 2004; 109(4): 537 - 543.
[Abstract] [Full Text] [PDF]


Home page
Circ. Res.Home page
M. E. Mendelsohn and G. M.C. Rosano
Hormonal Regulation of Normal Vascular Tone in Males
Circ. Res., December 12, 2003; 93(12): 1142 - 1145.
[Full Text] [PDF]